Glaukos Corp - SIC # 3842 - ORTHOPEDIC, PROSTHETIC, AND SURGICAL APPLIANCES AND SUPPLIES

Ticker Exchange SIC # Website Latest Ticker
GKOS New York 3842 https://www.glaukos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Glaukos Corp

Foreign Currency Headwinds Dragged Glaukos Corporation (GKOS) Shares in Q4 - Feb 27th, 2023 12:27 pm
Glaukos Submits New Drug Application to U.S. FDA for iDose TR - Feb 27th, 2023 12:00 pm
Glaukos Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags - Feb 24th, 2023 10:52 am
Glaukos' (GKOS) Q4 Earnings Beat Estimates, Sales Decline Y/Y - Feb 23rd, 2023 3:23 pm
Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates - Feb 22nd, 2023 10:55 pm
Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results - Feb 22nd, 2023 9:05 pm
MedTech Stocks' Q4 Earnings on Feb 22: FMS, GKOS & More - Feb 21st, 2023 3:06 pm
Glaukos Announces Participation in the Citi Healthcare Conference - Feb 15th, 2023 12:00 pm
15 Small Innovative Companies According to the Media - Feb 10th, 2023 12:40 pm
Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22 - Feb 1st, 2023 12:00 pm
15 Largest Ophthalmology Companies in the World - Jan 31st, 2023 2:25 pm
Glaukos Announces Positive Results for iDose TR Exchange Trial, Highlighting Favorable Safety and Tolerability - Jan 10th, 2023 9:05 pm
Glaukos Announces Positive Clinical Updates for Several Corneal Health Pipeline Programs - Jan 10th, 2023 9:05 pm
Here's Why You Should Retain Glaukos (GKOS) in Your Portfolio - Jan 6th, 2023 3:11 pm
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference - Dec 28th, 2022 9:15 pm
3 Reasons to Retain Glaukos (GKOS) Stock in Your Portfolio - Dec 28th, 2022 4:06 pm
Glaukos (GKOS) Up 0.8% Since Last Earnings Report: Can It Continue? - Dec 2nd, 2022 4:31 pm
Despite currently being unprofitable, Glaukos (NYSE:GKOS) has delivered a 79% return to shareholders over 5 years - Nov 26th, 2022 12:25 pm
Here's Why Glaukos (GKOS) Could be Great Choice for a Bottom Fisher - Nov 7th, 2022 2:55 pm
Glaukos Announces Participation in the Stephens Annual Investment Conference - Nov 7th, 2022 12:00 pm